UY29207A1 - Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamida - Google Patents

Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamida

Info

Publication number
UY29207A1
UY29207A1 UY29207A UY29207A UY29207A1 UY 29207 A1 UY29207 A1 UY 29207A1 UY 29207 A UY29207 A UY 29207A UY 29207 A UY29207 A UY 29207A UY 29207 A1 UY29207 A1 UY 29207A1
Authority
UY
Uruguay
Prior art keywords
phenyl
acetamide
hydroxy
amino
salt
Prior art date
Application number
UY29207A
Other languages
English (en)
Spanish (es)
Inventor
Kim James
Stefan Colin John Taylor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY29207A1 publication Critical patent/UY29207A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UY29207A 2004-11-12 2005-11-11 Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamida UY29207A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0425057A GB0425057D0 (en) 2004-11-12 2004-11-12 L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide

Publications (1)

Publication Number Publication Date
UY29207A1 true UY29207A1 (es) 2006-06-30

Family

ID=33523659

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29207A UY29207A1 (es) 2004-11-12 2005-11-11 Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamida

Country Status (8)

Country Link
AR (1) AR055282A1 (fr)
GB (1) GB0425057D0 (fr)
GT (1) GT200500328A (fr)
NL (1) NL1030405C2 (fr)
PE (1) PE20061131A1 (fr)
TW (1) TW200630324A (fr)
UY (1) UY29207A1 (fr)
WO (1) WO2006051375A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2320961B1 (es) * 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
EP2196465A1 (fr) 2008-12-15 2010-06-16 Almirall, S.A. Dérivés de (3-oxo)pyridazin-4-ylurée comme inhibiteurs de PDE4
EP2228368A1 (fr) 2009-03-12 2010-09-15 Almirall, S.A. Procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-ph2nyl2thoxy)hexyl]amino}-1-hydroxy2thyl)-8-hydroxyquinolin-2(1h)-one
WO2011061527A1 (fr) 2009-11-17 2011-05-26 Astrazeneca Ab Combinaisons qui comprennent un modulateur du récepteur glucocorticoïde, destinées au traitement de maladies respiratoires
EP2394998A1 (fr) 2010-05-31 2011-12-14 Almirall, S.A. Dérivés de 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl en tant qu'inhibiteurs de la PDE4
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
EP2578570A1 (fr) 2011-10-07 2013-04-10 Almirall, S.A. Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
EP2641900A1 (fr) 2012-03-20 2013-09-25 Almirall, S.A. Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2
WO2019071147A1 (fr) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. Inhibiteurs de la kinase p38 réduisant l'expression du gène dux4 et des gènes aval pour le traitement de la fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2298511T3 (es) * 2002-04-25 2008-05-16 Glaxo Group Limited Derivados de fenetanolamina.
EP1460064A1 (fr) * 2003-03-14 2004-09-22 Pfizer Limited Derivés de Indole-2-carboxamide comme beta-2 agonistes
EP1577291A1 (fr) * 2004-03-17 2005-09-21 Pfizer Limited Dérivés béta-2 agonistes de la phényléthanolamine

Also Published As

Publication number Publication date
TW200630324A (en) 2006-09-01
WO2006051375A1 (fr) 2006-05-18
GB0425057D0 (en) 2004-12-15
AR055282A1 (es) 2007-08-15
GT200500328A (es) 2006-06-02
NL1030405A1 (nl) 2006-05-15
PE20061131A1 (es) 2006-10-20
NL1030405C2 (nl) 2006-12-12

Similar Documents

Publication Publication Date Title
UY29207A1 (es) Sal l-tartrato de n-1-adamantil-2-(3-((2r)-2-(((2r)-2-hidroxi-2-(4-hidroxi-3-hidroximetil)fenil)etil)amino)propil)fenil)acetamida
BRPI0719210A2 (pt) Uso de compostos espiro-oxindol como agentes terapêuticos
EA200970140A1 (ru) Производные и аналоги n-этилхинолонов и n-этилазахинолонов
CR10245A (es) "nuevas combinaciones terapéuticas para el tratamiento de la depresión"
ECSP23034537A (es) Formulaciones farmaceuticas
BRPI0810863A2 (pt) Uso de hidrolisados de proteína para estabilizar formulações de detergente de metaloprotease.
BRPI0822033A2 (pt) Composto ou sal do mesmo, composição farmacêutica, uso de um composto ou sal, e, kit
GT200600316A (es) Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
DK1750683T3 (da) Formuleringer med langvarig frigivelse
CL2007002837A1 (es) Uso de fenitoina para tratar mucositis oral.
CY2013046I1 (el) Καινοτομος χρηση των αντισωματων αντι il-1bhta
DE102006051625A8 (de) Kombinationstherapie substituierter Oxazolidinone
ATE450243T1 (de) Haarpflegezusammensetzung
BRPI0814034A2 (pt) Uso de compostos à base de lantibiótico tipo-b com atividade antimicrobiana
UY30610A1 (es) Moduladores de mglur5
NI200900071A (es) Compuestos de pirozolina y su uso y composiciones farmacéuticas. pc 33496a.
DE602005026550D1 (de) Hydrierten nitrilkautschuk enthaltende zusammensetzung
BRPI0815596A2 (pt) Uso de compostos de sulfonanilida como herbicida
CR9144A (es) Formulaciones de benzoxazoles sustituidos
BRPI0820941A2 (pt) Uso de combinações de substâncias ativas para o combate de parasitas de animais.
BRPI0915336A2 (pt) composto capaz de inibir a atividade de uma pad, composição, e, uso de um composto
NO20043305D0 (no) Preparation of lodixanol
BRPI0913297A2 (pt) composição, farmacêutica, uso de uma composição, e, kit terapêutico.
BRPI0815455A8 (pt) compostos, composição farmacêutica, composição cosmética, uso cosmético de uma composição
PA8720601A1 (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevenciòn de trastornos psicoticos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160525